Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 37.93
-1.02 (-2.62%)
Sep 2, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.7 billion as of September 1, 2026. Its market cap has decreased by -0.64% in one year.
Market Cap
5.70B
Enterprise Value
4.54B
Revenue
459.42M
Ranking
n/a
PE Ratio
255.90
Stock Price
37.93
ChartMarket Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.70B, a decrease of -30.73%. That is a compound annual growth rate of -7.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.70B | 3.10% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 6.38B |
| Novogene | 6.29B |
| Youcare Pharmaceutical Group | 5.96B |
| Wuhan Keqian Biology Co.,Ltd | 5.85B |
| PharmaResources (Shanghai) | 5.50B |
| R&G PharmaStudies | 5.15B |
| Shenzhen Weiguang Biological Products | 5.15B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.97B |